ReviewEcoHealth2026
Mitigating Antimicrobial Resistance Through an Ecological One-Health Framework.
Review in EcoHealth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Antimicrobial resistance (AMR) represents one of the most pressing global health and ecological challenges of the twenty-first century. Resistant organisms and genes move freely across humans, animals, food systems, and the environment, with wastewater, soil, and wildlife acting as critical reservoirs. This interconnectedness highlights the need for a coordinated One Health framework that recognises AMR as both a medical and ecological crisis. In this review, we examine the mechanisms driving the emergence and dissemination of AMR and explore how stewardship, ecological management, and policy interventions can be integrated to mitigate its spread. We particularly consider how selective pressures operating across clinical and environmental settings influence resistance persistence and transmission. Evidence shows that judicious antimicrobial use in healthcare and veterinary medicine, coupled with environmental safeguards such as wastewater management and effluent regulation, can reduce selective pressure and transmission risk. Case studies illustrate how coordinated surveillance across sectors provides early warning of emerging resistomes, while stewardship programmes prolong the efficacy of existing antibiotics. Together, these findings highlight the importance of integrated responses that address resistance across interconnected human, animal, and environmental systems. By situating AMR within the broader human-animal-environment interface, this review underscores the critical importance of ecological thinking in designing sustainable solutions. Embedding One Health principles into global and national action plans is essential to safeguard biodiversity, strengthen resilience, and preserve the effectiveness of antimicrobials for future generations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.